ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.373
+0.073 (3.16%)
Mar 9, 2026, 2:18 PM EDT - Market open
ProKidney Revenue
ProKidney had revenue of $217.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $744.00K. In the year 2024, ProKidney had annual revenue of $76.00K.
Revenue (ttm)
$744.00K
Revenue Growth
n/a
P/S Ratio
966.39
Revenue / Employee
$3,647
Employees
204
Market Cap
713.76M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MiMedx Group | 418.63M |
| Gyre Therapeutics | 107.27M |
| Theravance Biopharma | 80.33M |
| Lexicon Pharmaceuticals | 49.80M |
| Prime Medicine | 4.63M |
PROK News
- 5 weeks ago - ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably - Seeking Alpha
- 7 weeks ago - ProKidney Corp. (PROK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates - GlobeNewsWire
- 4 months ago - ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025 - GlobeNewsWire
- 4 months ago - ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference - GlobeNewsWire
- 5 months ago - ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025 - GlobeNewsWire
- 6 months ago - ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy - Seeking Alpha